» Articles » PMID: 2426276

Acute Leukemia in a Patient Cured of Diffuse Histiocytic Lymphoma

Overview
Specialty Oncology
Date 1986 Jan 1
PMID 2426276
Authors
Affiliations
Soon will be listed here.
Abstract

A patient is described who, after completing treatment for diffuse histiocytic lymphoma, remained disease-free for 7 years (presumably cured), then developed acute nonlymphocytic leukemia (ANLL) after a brief preleukemic phase. Marrow cytogenetic analysis at the onset of frank leukemia revealed loss of chromosomes 5 and 7, which is consistent with secondary leukemia. She received only chemotherapy for her lymphoma, including high doses of an alkylating agent and a nitrosourea, which may have contributed to the development of the leukemia. This case report suggests that secondary ANLL may complicate the course of some long-term disease-free survivors of diffuse histiocytic lymphoma.

References
1.
Schein P, Devita Jr V, Hubbard S, Chabner B, Canellos G, Berard C . Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med. 1976; 85(4):417-22. DOI: 10.7326/0003-4819-85-4-417. View

2.
Pedersen-Bjergaard J, Larsen S . Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease. N Engl J Med. 1982; 307(16):965-71. DOI: 10.1056/NEJM198210143071601. View

3.
Wilson B, VANSLYCK E . Coexistent lymphosarcoma and chronic granulocytic leukemia. Cancer. 1966; 19(6):809-16. DOI: 10.1002/1097-0142(196606)19:6<809::aid-cncr2820190610>3.0.co;2-v. View

4.
Ezdinli E, Pocock S, BERARD C, AUNGST C, Silverstein M, Horton J . Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas: a progress report. Cancer. 1976; 38(3):1060-8. DOI: 10.1002/1097-0142(197609)38:3<1060::aid-cncr2820380304>3.0.co;2-v. View

5.
Devita Jr V, Canellos G, Chabner B, Schein P, Hubbard S, Young R . Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet. 1975; 1(7901):248-50. DOI: 10.1016/s0140-6736(75)91142-3. View